River 2 Renal Corp.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury (NCT07625553) | River 2 Renal Corp. | 2026-04-07 |
| To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF) (NCT06264310) | River 2 Renal Corp. | 2024-03-01 |
| Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome (NCT05875948) | River 2 Renal Corp. | 2023-06-30 |
Track River 2 Renal Corp. automatically
Every clearance here is in the API, with alerts when new ones post.